Laryngopharyngeal reflux disease (LPRD) is caused by the back-flow of stomach contents and/or gastric acid into the laryngopharynx.
Abstract
Laryngopharyngeal reflux disease (LPRD) is caused by the back-flow of stomach contents and/or gastric acid into the laryngopharynx. Symptoms of laryngopharyngeal reflux (LPR) include hoarseness, sore throat, throat-clearing, chronic cough, globus sensation, dysphagia, and postnasal drip. LPRD is diagnosed in approximately 10% of patients presenting to outpatient otolaryngology clinics and in more than 50% of patients presenting with voice complaints. Gastroesophageal reflux disease (GERD) and LPRD may be associated with periodontitis, sleep disorders, and otolaryngology disease. Gastric acid reflux with LPRD is thought to cause laryngeal granulomas. The most useful endolaryngeal signs for diagnosing LPRD are erythema, edema, and interarytenoid hypertrophy. Ambulatory 24-h dualprobe pH monitoring can be misleading; falsepositive outcomes may occur due to artifacts in the upper probe, and false-negative outcomes can occur as a result of the intermittent character of reflux episodes. In patients with LPRD, proton pump inhibitors (PPIs) have been shown to significantly improve reflux laryngitis. However, some patients are resistant to antacid therapy. Nocturnal acid breakthrough (NAB) on PPI has been suggested as one reason for resistance to PPI therapy. Administration of a PPI with the additional bedtime administration of a histamine-2 receptor antagonist has been shown to be an effective treatment of LPRD with NAB. Recently, potassium-competitive acid blockers have been proposed as an effective treatment of antacidresistant disease.
Introduction
Gastroesophageal reflux (GER), defined as the entry of gastric contents into the esophagus, is a common disorder encountered in clinical practice and is usually treated with proton pump inhibitors (PPIs LPRD has a significant impact on health-related quality of life (HRQOL). In addition to suffering from heartburn and abdominal pain, patients may worry that these symptoms represent an early warning sign of cancer (7) . Hence, the effect of PPI therapy on HRQOL is an important component of treatment (5) .
In this article, we review the definition, epidemiology, pathophysiology, symptoms, examination, diagnosis, and treatment of LPRD.
Definition
Gastroesophageal reflux disease secondary increase in throat-clearing, and increased laryngeal muscle tone (10).
Epidemiology
It has been estimated that 15 to 20% 
Pathophysiology
In LPRD, gastric acid reflux is thought to cause laryngeal granuloma formation (16) (Figure 1 
Examination

Complications
Periodontitis
GERD has been shown to be an independent risk factor for chronic periodontitis, regardless of the presence of other established risk factors such as dental caries, tobacco use, or a history of calcium channel blocker, cyclosporine, or phenytoin use (35) . Significant associations between GERD, tooth loss, and functional dyspepsia (FD) have been observed in women, but not in men.
Furthermore, a significant relationship exists between tooth loss and components of FD, such as early satiety (36) .
However, the association between periodontitis and LPRD remains unclear.
Sleep disorders
Previous research has demonstrated an association between GERD and sleep disturbances, such as obstructive sleep apnea (OSA), daytime sleepiness, and insomnia (37) . In patients with OSA, LPR is accompanied by both respiratory and spontaneous arousals (38). Furthermore, LPR is frequently noted in children with otitis media with effusion (OME) (39) . These data suggest an association between CRS and LPR (40).
Otolaryngology disease
Treatment
Patients with extraesophageal manifestations of GERD may require higher doses of acid suppressive therapy and longer treatment duration to control their symptoms (41). PPI therapy may aid in the diagnosis and treatment of atypical GERD affecting the larynx when used as a therapeutic trial in patients with symptoms suggesting LPR (28, 42, 43, 44) .
Placebo-controlled studies of PPIs in
LPRD demonstrated a significant improvement in reflux laryngitis following PPI treatment (45, 46) .
However, several recent reviews have concluded that, to date, the data are insufficient to support the regular use of PPIs in LPRD (47, 48, 49) . An alternative therapeutic strategy is anti-reflux surgery, such as Nissen fundoplication (50) .
Some LPRD patients are resistant to antacid therapy (51) . One reasons for PPI resistance in LPRD may be mutations in cytochrome P450, which can lead to altered metabolism of PPIs (52, 53, 54) .
Recently 
Conclusions
LPRD is a gastric acid-related disease that is usually diagnosed by otolaryngologists and gastroenterologists.
LPRD is related to periodontitis, sleep disorders, and otolaryngeal disease.
Future studies are required to clarify the pathophysiology and treatment of LPRD. 
